AlJazira Capital sets Jamjoom Pharma’s TP, rating after Q3 2025 results

25/10/2025 Argaam

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) posted a Q3 2025 net income of SAR 106.7 million, missing AlJazira Capital and mar

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe

Most Read